Literature DB >> 1966325

Human papillomavirus infection in the cervix of pregnant females in Hong Kong.

R J Collins1, H Y Ngan, C Hsu, A Cheung, P King, T C Pun, H K Ma, G Srivastava.   

Abstract

Routine cytological examination and HPV-DNA probing were performed on cervical cells obtained from 215 pregnant Chinese females. The procedure utilized the specific binding of a mixture of complementary [32P]-labelled RNA probes to membrane-bound target HPV DNA types 6, 11, 16, 18, 31, 33 and 35. Positive results for HPV-DNA were obtained in 11/215 (5%) of the cases. The cervical smears were routinely processed and in 3/215 (1.5%) cases a cytological diagnosis of wart virus infection was made. All three were included in the 11 probe-positive cases. Using similar molecular biological techniques, pregnant Western females have an incidence of HPV infection of the cervix which is up to five times that of the present series. This is an unexpected finding in view of the fact that the incidence of cervical cancer is higher in Chinese women than American women.

Entities:  

Mesh:

Year:  1990        PMID: 1966325     DOI: 10.1111/j.1365-2303.1990.tb00340.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

1.  Prevalence of low and high risk human papillomavirus types in cervical cells from Hong Kong pregnant Chinese using filter in situ hybridization.

Authors:  E W Ip; R J Collins; A N Cheung; G Srivastava
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

2.  Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.

Authors:  H Y Ngan; S W Tsao; S S Liu; M Stanley
Journal:  Genitourin Med       Date:  1997-02

3.  Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination.

Authors:  K Johnson
Journal:  CMAJ       Date:  1995-02-15       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.